Your browser doesn't support javascript.
loading
Real-world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance.
Yamazaki, Naoya; Kiyohara, Yoshio; Uhara, Hisashi; Tsuchida, Tetsuya; Maruyama, Keiko; Shakunaga, Naoki; Itakura, Eijun; Komoto, Akira.
Affiliation
  • Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kiyohara Y; Dermatology Division, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.
  • Uhara H; Department of Dermatology, Sapporo Medical University, Sapporo, Japan.
  • Tsuchida T; Department of Dermatology, Saitama Medical University, Moroyama, Japan.
  • Maruyama K; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Shakunaga N; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Itakura E; Bristol-Myers Squibb K.K., Tokyo, Japan.
  • Komoto A; Bristol-Myers Squibb K.K., Tokyo, Japan.
J Dermatol ; 47(8): 834-848, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32515086

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2020 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2020 Document type: Article Affiliation country: Japan Country of publication: United kingdom